Biohaven (BHVN) Net Cash Flow (2021 - 2026)
Biohaven (BHVN) posted Net Cash Flow of $44.3 million for Q1 2026, little changed sequentially from $44.4 million in Q4 2025, and up 35633.87% YoY from N/an in Q1 2025.
Biohaven (BHVN) Net Cash Flow (2021 - 2026) Analysis & Trends
Biohaven has reported Net Cash Flow for 6 years, with the latest figure at $44.3 million in Q1 2026.
- Quarterly Net Cash Flow rose 35633.87% year-over-year to $44.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $174.4 million (up 306.8% YoY) and the FY2025 annual result came in at $130.2 million, up 187.03% from the prior year.
- Net Cash Flow held at $44.3 million in Q1 2026 per BHVN's latest filing, from $44.4 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $190.8 million in Q4 2022 and troughed at -$154.3 million in Q3 2024.
- A 5-year average of $11.8 million and a median of $14.4 million in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2023 and 2026: Net Cash Flow tumbled 376.48% in 2023, then jumped 35633.87% in 2026.
- Over 5 years, Net Cash Flow stood at $190.8 million in 2022, then tumbled by 33.72% to $126.4 million in 2023, then sank by 88.58% to $14.4 million in 2024, then jumped by 207.55% to $44.4 million in 2025, then declined by 0.19% to $44.3 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $44.3 million, $44.4 million, and $19.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - | -36.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -36.48 Mn |
| Jun 30, 2026 | -36.48 Mn |
| Mar 31, 2026 | 44.31 Mn |
| Mar 31, 2026 | 44.31 Mn |
| Dec 31, 2025 | 44.40 Mn |
| Dec 31, 2025 | 44.40 Mn |
| Sep 30, 2025 | 19.37 Mn |
| Sep 30, 2025 | 19.37 Mn |
| Jun 30, 2025 | 66.35 Mn |
| Jun 30, 2025 | 66.35 Mn |
| Mar 31, 2025 | 124,000.00 |
| Mar 31, 2025 | 124,000.00 |
| Dec 31, 2024 | 14.44 Mn |
| Dec 31, 2024 | 14.44 Mn |
| Sep 30, 2024 | -154.30 Mn |
| Sep 30, 2024 | -154.30 Mn |
| Jun 30, 2024 | 55.39 Mn |
| Jun 30, 2024 | 55.39 Mn |
| Mar 31, 2024 | -65.18 Mn |
| Mar 31, 2024 | -65.18 Mn |